BTI
VIR icon

Blue Trust Inc’s Vir Biotechnology VIR Stock Holding History

Blue Trust Inc’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,989
Closed -$35.5K – 2990
2024
Q3 		$35.5K Buy
3,989
+2,351
+144% +$20.4K ﹤0.01% 1711
2024
Q2 		$16.6K Buy
1,638
+1,621
+9,535% +$15.5K ﹤0.01% 1744
2024
Q1 		$172 Buy
17
+2
+13% +$20 ﹤0.01% 2085
2023
Q4 		$0 Sell
15
-1,542
-99% -$14.1K ﹤0.01% 2705
2023
Q3 		$39K Buy
1,557
+522
+50% +$7.45K ﹤0.01% 934
2023
Q2 		$24K Sell
1,035
-4,565
-82% -$115K ﹤0.01% 991
2023
Q1 		$141K Buy
5,600
+4,937
+745% +$126K ﹤0.01% 657
2022
Q4 		$12K Buy
663
+653
+6,530% +$16K ﹤0.01% 1488
2022
Q3 		$0 Buy
+10
New +$254 ﹤0.01% 2341

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return